These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 17196850

  • 1. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT.
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract] [Full Text] [Related]

  • 2. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S, Flather M, Mister R, Delahunty N, Fowkes G, Bradbury A, Stansby G.
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
    [Abstract] [Full Text] [Related]

  • 3. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 4. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Jan; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 6. How many claudicants should be prescribed statins?
    Harrison EM, Holdsworth RJ.
    Eur J Vasc Endovasc Surg; 2003 Apr; 25(4):367-8. PubMed ID: 12651177
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI.
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract] [Full Text] [Related]

  • 9. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H, Strandberg TE, Tikkanen I, Kauhanen P, Lepäntalo M.
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [Abstract] [Full Text] [Related]

  • 10. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS, Silverman SH, Lip GY.
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract] [Full Text] [Related]

  • 11. Control of hypertension in patients with peripheral artery disease.
    Clement DL.
    Blood Press; 2006 Apr; 15(4):251-2. PubMed ID: 17078187
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral arterial disease.
    Hiatt WR, Nehler MR.
    Adv Intern Med; 2001 Apr; 47():89-110. PubMed ID: 11795081
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [From clinical observation to assessment of practices: guidelines for hypertension management].
    Bobrie G, Durieux P, Postel-Vinay N, Plouin PF, French Society of Nephrology.
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S240-5. PubMed ID: 19596342
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.